Vanguard Group Inc Fulcrum Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,538,665 shares of FULC stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,538,665
Previous 2,519,984
0.74%
Holding current value
$15.2 Million
Previous $17 Million
40.89%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding FULC
# of Institutions
136Shares Held
43.7MCall Options Held
3.12MPut Options Held
128K-
Rtw Investments, LP New York, NY5.85MShares$35 Million0.89% of portfolio
-
Cowen And Company, LLC3.71MShares$22.2 Million1.18% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.85MShares$17 Million1.15% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$14 Million10.72% of portfolio
-
Black Rock Inc. New York, NY1.54MShares$9.22 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $311M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...